Home > Press > Applied Nanoscience Announces International Patent Developments and Expansion of Intellectual Property Portfolio
Abstract:
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN) today announced that it has received formal notification for the issuance of a patent in Singapore for its core technology platform encompassing "Filtering Devices Incorporating Nanoparticles." The Company has already been issued this similarly broad patent in Taiwan. The patent covers three main ways of associating the nanoparticles with filter media: (1) having pellets of nanoparticles located adjacent to the filter media, (2) coating the filter media with a powder of nanoparticles, and (3) impregnating the nanoparticles into the filter media.
In addition, ANI has received formal communication that the issuance of this same patent is imminent in Russia along with written confirmation that the granting of a patent based upon a divisional application is expected soon in India.
"We are pleased with this recent trend of valuable developments tied to our global intellectual property efforts. We should be in a position in the very near future to disclose additional IP growth thanks to diligent efforts in over 50 countries," said Thomas K. Allen, President and CEO, ANI. "This protection, coupled with our proprietary silver NanoFense™ Technology, makes for attractive licensing opportunities within identified market segments."
The Company has received very positive notification relating to the patent application on their proprietary nanoparticle formulation from the USPTO.
####
About Applied Nanoscience Inc.
Applied Nanoscience Inc. is a marketer and developer of innovative, high-performance filtration systems and technologies to customers worldwide in a focused effort to provide a safer tomorrow.
Safe Harbor Statement
This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. ANI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the companies could differ significantly from such forward-looking statements.
For more information, please click here
Contacts:
Philippe Niemetz
PAN Consultants Ltd.
800-477-7570
or
212-344-6464
Investor Relations
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||